On Tuesday, FibroGen Inc (NASDAQ: FGEN) was -8.46% drop from the session before settling in for the closing price of $0.32. A 52-week range for FGEN has been $0.18 – $1.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -28.29% over the past five years. When this article was written, the company’s average yearly earnings per share was at -23.96%. With a float of $94.08 million, this company’s outstanding shares have now reached $100.92 million.
Let’s look at the performance matrix of the company that is accounted for 225 employees. In terms of profitability, gross margin is 47.47%, operating margin of -507.82%, and the pretax margin is -517.78%.
FibroGen Inc (FGEN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward FibroGen Inc stocks. The insider ownership of FibroGen Inc is 6.90%, while institutional ownership is 35.95%. The most recent insider transaction that took place on Mar 24 ’25, was worth 50,663. In this transaction CEO of this company bought 145,000 shares at a rate of $0.35, taking the stock ownership to the 543,329 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director bought 250,000 for $0.35, making the entire transaction worth $88,000. This insider now owns 323,722 shares in total.
FibroGen Inc (FGEN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -23.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.51% during the next five years compared to 11.75% growth over the previous five years of trading.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
You can see what FibroGen Inc (FGEN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach -0.78 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
FibroGen Inc (NASDAQ: FGEN) saw its 5-day average volume 0.5 million, a negative change from its year-to-date volume of 2.73 million. As of the previous 9 days, the stock’s Stochastic %D was 39.50%. Additionally, its Average True Range was 0.03.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 9.45%, which indicates a significant decrease from 25.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.65% in the past 14 days, which was lower than the 122.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3411, while its 200-day Moving Average is $0.4342. Nevertheless, the first resistance level for the watch stands at $0.3138 in the near term. At $0.3365, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3528. If the price goes on to break the first support level at $0.2748, it is likely to go to the next support level at $0.2585. Assuming the price breaks the second support level, the third support level stands at $0.2358.
FibroGen Inc (NASDAQ: FGEN) Key Stats
There are 101,044K outstanding shares of the company, which has a market capitalization of 29.42 million. As of now, sales total 29,620 K while income totals -47,580 K. Its latest quarter income was 46,330 K while its last quarter net income were -17,080 K.
